Biosensors market in 2025 is driven by advanced healthcare applications, dominated by oxidoreductase enzymes and non-wearable ...

The global wearable medical devices market size surpassed USD 42.71 billion in 2024 and is anticipated to reach around USD 430.76 billion by 2034, registering a CAGR of 26% from 2025 to 2034. A study ...

The global biosensors market is set for substantial growth, with a projected increase in market value from US$ 32.14 billion in 2024 to US$ 75.84 billion by 2033, reflecting a compound annual growth ...

From artificial intelligence (AI) to telemedicine and wearable health devices, innovations are redefining how care is ...

Researchers in the US have developed a prototype of a wearable device that can monitor oestrogen in sweat and could play a role in women’s health and fertility. According to a team from the ...

As per Vantage Market Research, the surge in cloud computing is poised to inject substantial momentum into the health ...

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, despite significant advancements in diagnosis and treatment. However, the integration of artificial ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

In this rapidly growing digital era, cloud application architecture and distributed real-time systems are redefining ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring ...